Evidence basis note: This page draws from regulator statements, official trial records, peer-reviewed clinical studies, drug-development reports, and scientific databases
Just targeted support that helps your system get back into rhythm
Fiber Constipation is one of the most common digestive side effects reported while using GLP-1 medications
In summary, the growing body of evidence positions GLP-1 receptor agonists as essential medications at the intersection of endocrinology and cardiovascular medicine
Reducing secondary neuronal death has become a central focus of current treatment strategies (223, 224), and modulating ferroptosis is emerging as a promising approach for neuroprotection after TBI (225)
When combined with lifestyle changes, medical guidance, and ongoing support, these therapies can help patients make sustainable progress toward their health goals